Compare iShares MSCI Germany (DAX) (EWG) vs Nuwellis Inc (NUWE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
iShares MSCI Germany (DAX) vs Nuwellis Inc — how do they compare? iShares MSCI Germany (DAX) trades at $41.98 (market cap $1.42B), while Nuwellis Inc trades at $0.68 (market cap $2.20M). The key difference: iShares MSCI Germany (DAX) is far larger — about 645.5× Nuwellis Inc's market cap, and iShares MSCI Germany (DAX) is trading nearer its 52-week high, Nuwellis Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold iShares MSCI Germany (DAX) for 56 Days and Nuwellis Inc for 26 Days on average.
| EWG | NUWE | |
|---|---|---|
Market Cap | $1.42B | $2.20M |
Volume | 1,110,573 | 121,544 |
Sector | Broad Market / Factor | Health |
52-Week High | $44.59 | $146.65 |
52-Week Low | $38.08 | $0.68 |
Typical Hold Time | 56 Days | 26 Days |
Enterprise Value | — | -$1.52M |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
EWG is trading at $40.91, down 1.4% today amid bearish technical signals with 19 sell indicators versus 1 buy. The stock faces resistance at $41 with support at $40, while European market sentiment remains cautious due to ECB rate hike expectations and energy price pressures. Key financial ratios are unavailable in the current dataset.
The outlook remains cautious with technical indicators signaling bearish momentum and European macroeconomic headwinds from potential ECB tightening. Investment opportunities depend on resolution of energy inflation concerns, while risks include further rate hikes and deteriorating eurozone business confidence.
NUWE trades at $0.6907, down 1.48% on the day, with a bearish technical signal from moving averages despite oversold RSI readings. The company reported revenue growth to $9M in 2026 but remains deeply unprofitable with a net income margin of -125.63%. Recent news highlights console sales growth and strategic expansions in pediatric and critical care markets.
The outlook is high-risk due to persistent losses and negative cash flow, though analyst sentiment is split with a 50% buy rating. Investment potential hinges on the company's ability to achieve profitability and scale its Aquadex platform, while risks include cash burn and competitive pressures in the medical device sector.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About iShares MSCI Germany (DAX)
EWG is a country-specific ETF that tracks the performance of the German equity market. It provides exposure to large and mid-sized companies in Germany across key sectors like industrials and financials, with top holdings such as SAP, Siemens, and Allianz.
Read more on EWG →About Nuwellis Inc
Nuwellis, Inc. is a medical device company focused on developing and commercializing fluid management solutions. The company's primary product is an ultrafiltration system used in hospitals to remove excess fluid from patients with fluid overload, often associated with conditions such as heart and kidney failure. Nuwellis aims to improve patient outcomes and reduce healthcare costs through its specialized, innovative therapies.
Read more on NUWE →
